The sensors, manufactured and sold by DexCom, a San Diego-based diabetes care company, have received FDA approval for OTC use. Abbott Laboratories, another key player in the market, is set to release its own system in the summer of 2024, although pricing details have not yet been disclosed.
Experts estimate the market for these products could encompass up to 100,000 people, including prediabetic individuals and those with diabetes who do not use insulin.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
